Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier A Membrilla

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Cephalalgia : an International Journal of Headache|February 15, 2022
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patientsDavid Garcia-Azorin, Almudena Layos-Romero, Jesús Porta-Etessam, et al.
European Journal of Neurology|February 7, 2024
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC studyAna Beatriz Gago-Veiga, Noelia Lopez-Alcaide, Sonia Quintas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 22, 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real worldEdoardo Caronna, Victor José Gallardo, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache|June 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Cephalalgia : an International Journal of Headache|February 15, 2022
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patientsDavid Garcia-Azorin, Almudena Layos-Romero, Jesús Porta-Etessam, et al.
European Journal of Neurology|February 7, 2024
Evaluation of the concomitant use of prophylactic treatments in patients with migraine under anti-calcitonin gene-related peptide therapies: The PREVENAC studyAna Beatriz Gago-Veiga, Noelia Lopez-Alcaide, Sonia Quintas, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 22, 2024
Redefining migraine prevention: early treatment with anti-CGRP monoclonal antibodies enhances response in the real worldEdoardo Caronna, Victor José Gallardo, Gabriella Egeo, et al.
Cephalalgia : an International Journal of Headache|June 19, 2026
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohortEdoardo Caronna, Rut Mas-de-Les-Valls, Gabriella Egeo, et al.
Pageof 2